New financing follows healthy climate for Minnesota medical companies.
latest articles
NBGH survey cites specialty drugs and high-cost employees as the top cost drivers.
The state is providing $182,000 as part of the company's multimillion dollar addition to its St. Cloud headquarters.
The new test focuses on a type of molecule in the blood stream that is heavily linked to cardiovascular disease processes.
The med-tech company will use the money to complete its final U.S. study and expand its global commercial activities.
DNT offers similar services as Marco and will allow the company to further expansion plans in the Midwest.
The food giant also described how it plans to potentially distribute stock once Save-A-Lot goes public.
Council members want assurances — first promised a year ago — that once the stadium is approved, the redevelopment of the shopping center adjacent to the stadium site will move ahead.
Each page, it seems, is packed with useable, reliable information and good advice. That is, as long as you have a well-paying job in place.
To: Tom Landwehr
DNR Commissioner
St. Paul, MN
Rapid company growth leads to a headquarters expansion and a move away from St. Paul.
Making the most of the sharing economy as an event planner.
For the first half of 2016, Stratasys has reported a net loss of $41.8 million, far less than the nearly $240 million loss it had endured during the first half of last year.
“The notion that we can’t tweet or do a social post congratulating a Minnesota athlete…was too much to take,” the company’s co-owner said.
Unequal medical outcomes, treatment resulting in trillions of dollars in extra costs.
LAgen Laboratories produces bioengineered retinal cells for pharma, others.